MX366793B - Metodos para preparar oxazolidinonas y composiciones que las contienen. - Google Patents

Metodos para preparar oxazolidinonas y composiciones que las contienen.

Info

Publication number
MX366793B
MX366793B MX2014004600A MX2014004600A MX366793B MX 366793 B MX366793 B MX 366793B MX 2014004600 A MX2014004600 A MX 2014004600A MX 2014004600 A MX2014004600 A MX 2014004600A MX 366793 B MX366793 B MX 366793B
Authority
MX
Mexico
Prior art keywords
methods
compositions containing
preparing
oxazolidinones
preparing oxazolidinones
Prior art date
Application number
MX2014004600A
Other languages
English (en)
Inventor
Carrie A Costello
Jaqueline A Simson
Robert J Duguid
Douglas Phillipson
Original Assignee
Merck Sharp & Dohme Corp Star
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme Corp Star filed Critical Merck Sharp & Dohme Corp Star
Publication of MX366793B publication Critical patent/MX366793B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Se describen métodos para preparar una clase de oxazolidinonas útiles para impedir el crecimiento bacteriano.
MX2014004600A 2008-10-10 2009-10-09 Metodos para preparar oxazolidinonas y composiciones que las contienen. MX366793B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10446908P 2008-10-10 2008-10-10
PCT/US2009/060267 WO2010042887A2 (en) 2008-10-10 2009-10-09 Methods for preparing oxazolidinones and compositions containing them

Publications (1)

Publication Number Publication Date
MX366793B true MX366793B (es) 2019-07-24

Family

ID=41382395

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2011003820A MX2011003820A (es) 2008-10-10 2009-10-09 Metodos para preparar oxazolidinonas y composiciones que las contienen.
MX2014004600A MX366793B (es) 2008-10-10 2009-10-09 Metodos para preparar oxazolidinonas y composiciones que las contienen.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2011003820A MX2011003820A (es) 2008-10-10 2009-10-09 Metodos para preparar oxazolidinonas y composiciones que las contienen.

Country Status (13)

Country Link
US (2) US8604209B2 (es)
EP (2) EP2346858B1 (es)
JP (1) JP5773875B2 (es)
KR (1) KR101674146B1 (es)
CN (2) CN106220621B (es)
AU (1) AU2009303301B2 (es)
CA (1) CA2738671C (es)
ES (2) ES2748505T3 (es)
HK (2) HK1200169A1 (es)
MX (2) MX2011003820A (es)
RU (2) RU2556234C2 (es)
SG (2) SG10201702946RA (es)
WO (1) WO2010042887A2 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
MX2011003820A (es) 2008-10-10 2011-06-16 Trius Therapeutics Metodos para preparar oxazolidinonas y composiciones que las contienen.
SG173497A1 (en) 2009-02-03 2011-09-29 Trius Therapeutics Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
WO2012033952A1 (en) 2010-09-10 2012-03-15 Micurx Pharmaceuticals, Inc. 3 - phenyl- 2 -oxo- 1, 3 -oxazolidines for treatment of bacterial infections
WO2016009401A2 (en) * 2014-07-18 2016-01-21 Dr. Reddy's Laboratories Limited Preparation of tedizolid phosphate
CN105367547B (zh) * 2014-08-19 2019-04-23 北京桦冠生物技术有限公司 一种噁唑啉酮抗生素的新合成工艺
WO2016041505A1 (zh) * 2014-09-17 2016-03-24 正大天晴药业集团股份有限公司 一种磷酸特地唑胺、其中间体以及它们的制备方法
CN104496979A (zh) * 2014-09-17 2015-04-08 博瑞生物医药技术(苏州)有限公司 一种噁唑烷酮类化合物及其中间体的制备方法
CN104327119A (zh) * 2014-10-17 2015-02-04 苏州明锐医药科技有限公司 磷酸泰地唑胺的制备方法
WO2016088102A1 (en) * 2014-12-05 2016-06-09 Sun Pharmaceutical Industries Limited Processes for the preparation of tedizolid phosphate and its intermediates
WO2016088103A1 (en) * 2014-12-05 2016-06-09 Sun Pharmaceutical Industries Limited A process for the preparation of tedizolid phosphate
WO2016088101A1 (en) * 2014-12-05 2016-06-09 Sun Pharmaceutical Industries Limited Processes for the preparation of tedizolid phosphate and its intermediates
WO2016088100A1 (en) * 2014-12-05 2016-06-09 Sun Pharmaceutical Industries Limited Processes for the preparation of tedizolid phosphate and its intermediates
CN104558034A (zh) * 2015-01-21 2015-04-29 齐鲁制药有限公司 磷酸特地唑胺二钠盐的新晶型及其制备方法
CN105837634B (zh) * 2015-01-30 2020-09-04 上海创诺制药有限公司 一种泰地唑胺磷酸酯结晶体及其制备方法
CN104592218B (zh) * 2015-02-13 2015-11-04 江苏欧信医药化工有限公司 一种泰地唑胺的合成方法
CN104892592A (zh) * 2015-03-30 2015-09-09 成都惟新医药科技有限公司 一种泰地唑胺的制备方法
CN106146485B (zh) * 2015-04-01 2021-04-30 上海迪赛诺化学制药有限公司 一种制备泰地唑胺的方法及其得到的泰地唑胺结晶体
CN106279281B (zh) * 2015-05-15 2018-08-03 重庆圣华曦药业股份有限公司 噁唑烷酮类抗菌素泰地唑胺磷酸酯的精制方法
CN106279282B (zh) * 2015-05-21 2019-08-23 博瑞生物医药（苏州）股份有限公司 一种磷酸特地唑胺的纯化方法
CN106317114B (zh) * 2015-07-02 2018-11-20 南京优科制药有限公司 一种磷酸特地唑胺的制备方法
CN105131037B (zh) * 2015-07-28 2017-05-03 济南爱思医药科技有限公司 一种高纯度泰地唑胺磷酸酯的制备方法
CN106632298B (zh) 2015-11-03 2021-06-01 上海科胜药物研发有限公司 一种泰地唑胺的制备方法及其中间体
KR101855334B1 (ko) 2015-12-11 2018-06-08 에스티팜 주식회사 옥사졸리디논 유도체의 중간체 제조방법
CN105418681A (zh) * 2015-12-15 2016-03-23 南京艾德凯腾生物医药有限责任公司 一种磷酸特地唑胺的制备方法
CN107488188B (zh) * 2016-06-12 2019-03-15 重庆圣华曦药业股份有限公司 一种制备特地唑胺关键中间体的合成方法
CN106146560B (zh) * 2016-07-12 2019-02-01 扬子江药业集团有限公司 一种高纯度磷酸特地唑胺的精制方法
CN106432182B (zh) * 2016-09-06 2019-04-30 铜仁学院 特地唑胺中间体的合成方法
CN106565680A (zh) * 2016-10-31 2017-04-19 瑞阳制药有限公司 特地唑胺杂质及其制备方法
CN108059624A (zh) * 2016-11-08 2018-05-22 上海医药工业研究院 用于制备咔哒唑胺关键中间体的制备方法
CN106632240A (zh) * 2016-11-25 2017-05-10 山东轩德医药科技有限公司 一种2‑甲基‑5‑(5‑溴吡啶‑2‑基)四氮唑的制备方法
CN106699730A (zh) * 2016-12-23 2017-05-24 山东轩德医药科技有限公司 2‑甲基‑5‑(5‑溴吡啶‑2‑基)四氮唑的制备方法
CN107722056A (zh) * 2017-10-31 2018-02-23 重庆华邦胜凯制药有限公司 磷酸特地唑胺的制备方法
EP3723758A4 (en) 2017-12-13 2021-06-23 Merck Sharp & Dohme Corp. PHARMACEUTICAL COMPOSITIONS OF TEDICOLIDE PHOSPHATE
CN110804038B (zh) * 2018-08-06 2021-03-05 上海博志研新药物技术有限公司 磷酸特地唑胺及其中间体的制备方法
CN110938058B (zh) * 2018-09-22 2022-04-12 南京优科生物医药研究有限公司 一种噁唑烷酮类抗生素中间体的制备方法
CN111116652A (zh) * 2019-12-06 2020-05-08 山东中医药大学 一种高纯度磷酸特地唑胺的制备方法
CN113121518B (zh) * 2019-12-31 2022-06-28 北京福元医药股份有限公司 一种特地唑胺杂质的制备方法
CN111285848A (zh) * 2020-04-10 2020-06-16 苏州敬业医药化工有限公司 一种5-溴-2-(2-甲基-2h-四唑-5-基)吡啶的纯化方法
WO2021258013A1 (en) 2020-06-18 2021-12-23 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof
CN114105946A (zh) * 2020-08-26 2022-03-01 浙江苏泊尔制药有限公司 一种磷酸特地唑胺中间体及其制备方法
CN112961186A (zh) * 2021-02-04 2021-06-15 海南通用康力制药有限公司 一种磷酸特地唑胺的纯化方法
CN113354620B (zh) 2021-07-05 2022-03-22 南京桦冠生物技术有限公司 一种特地唑胺中间体的高效制备方法及其中间体
CN113248471B (zh) * 2021-07-05 2021-09-21 南京桦冠生物技术有限公司 一种唑胺类药物中间体的制备方法及其中间体
CN113488445A (zh) * 2021-07-05 2021-10-08 合肥巨一动力系统有限公司 一种igbt封装散热结构及其应用的电机控制器
CN115873036A (zh) * 2022-09-30 2023-03-31 中国药科大学 一种磷酸特地唑胺的合成方法

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU80081A1 (fr) 1977-08-26 1979-05-15 Delalande Sa Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
US4128654A (en) 1978-02-10 1978-12-05 E. I. Du Pont De Nemours And Company 5-Halomethyl-3-phenyl-2-oxazolidinones
US4340606A (en) 1980-10-23 1982-07-20 E. I. Du Pont De Nemours And Company 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2500450A1 (fr) 1981-02-25 1982-08-27 Delalande Sa Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
US4461773A (en) 1982-09-15 1984-07-24 E. I. Dupont De Nemours And Company P-Oxooxazolidinylbenzene compounds as antibacterial agents
CA1320730C (en) 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US4948801A (en) 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
ATE146783T1 (de) 1991-11-01 1997-01-15 Upjohn Co Substituierte aryl- und heteroaryl- phenyloxazolidinone
SK283420B6 (sk) 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
PL175782B1 (pl) 1992-12-08 1999-02-26 Upjohn Co Nowe podstawione troponem pochodne fenylooksazolidynonowe
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
WO1995014684A1 (en) 1993-11-22 1995-06-01 The Upjohn Company Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
US6413981B1 (en) * 1999-08-12 2002-07-02 Ortho-Mcneil Pharamceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
JP2003535860A (ja) 2000-06-05 2003-12-02 ドン・ア・ファーム・カンパニー・リミテッド 新規なオキサゾリジノン誘導体及びその製造方法
US20020115669A1 (en) 2000-08-31 2002-08-22 Wiedeman Paul E. Oxazolidinone chemotherapeutic agents
US20050032861A1 (en) 2001-04-07 2005-02-10 Betts Michael John Oxazolidines containing a sulfonimid group as antibiotics
US6627646B2 (en) 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs
CA2459766A1 (en) 2001-09-11 2003-03-20 Astrazeneca Ab Oxazolidinone and/or isoxazoline as antibacterial agents
DE60210654T2 (de) 2001-10-25 2007-01-25 Astrazeneca Ab Aryl substituierte oxazolidinone mit antibacterieller activität
NZ515881A (en) 2001-12-03 2004-09-24 New Zealand Dairy Board Cheese flavour ingredient and method of its production
RU2004129278A (ru) 2002-02-28 2005-06-10 Астразенека Аб (Se) Химические соединения
US7473699B2 (en) * 2002-02-28 2009-01-06 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and their use as antibacterial agents
US7223870B2 (en) 2002-11-01 2007-05-29 Pfizer Inc. Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
MXPA05005651A (es) 2002-11-28 2005-07-27 Astrazeneca Ab Derivados de oxazolidinona y/o isoxazolina como agentes antibacterianos.
EP1581524A2 (en) 2002-11-28 2005-10-05 AstraZeneca AB Oxazolidinones as antibacterial agents
GB0229518D0 (en) * 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
TW200500360A (en) 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
GB0306358D0 (en) * 2003-03-20 2003-04-23 Astrazeneca Ab Chemical compounds
AU2004256085B2 (en) 2003-07-02 2007-12-06 Kyorin, Pharmaceutical Co., Ltd. Cyclopropyl Group Substituted Oxazolydinone Antibiotics and Derivatives Thereof
ATE471937T1 (de) 2003-07-02 2010-07-15 Merck Sharp & Dohme Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
WO2005051933A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby
TW200526649A (en) 2003-12-17 2005-08-16 Rib X Pharmaceuticals Inc Halogenated biaryl heterocyclic compounds and methods of making and using the same
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
US20070191336A1 (en) 2003-12-24 2007-08-16 Flynn Daniel L Anti-inflammatory medicaments
JP2008500317A (ja) 2004-05-25 2008-01-10 アストラゼネカ アクチボラグ 抗菌剤としての３−’４−｛６−置換アルカノイル）ピリジン−３−イル｝−３−フェニル−５−（１ｈ−１，２，３−トリアゾール−１−イルメチル）−１，３−オキサゾリジン−２−オン
US20080064689A1 (en) 2004-05-25 2008-03-13 Astrazeneca Ab 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents
GB0411596D0 (en) 2004-05-25 2004-06-30 Astrazeneca Ab Chemical process
JP2008500318A (ja) 2004-05-25 2008-01-10 アストラゼネカ アクチボラグ 抗菌剤としての３−｛４−（ピリジン−３−イル）フェニル｝−５−（１ｈ−１，２，３−トリアゾール−１−イルメチル）−１，３−オキサゾリジン−２−オン
AU2005247671A1 (en) 2004-05-25 2005-12-08 Astrazeneca Ab 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as MAO inhibitors for the treatment of bacterial infections
EP1799677A1 (en) 2004-10-08 2007-06-27 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2007023507A2 (en) 2005-06-20 2007-03-01 Wockhardt Limited Oxazolidinones bearing antimicrobial activity composition and methods of preparation
WO2007138381A2 (en) 2005-10-14 2007-12-06 Targanta Therapeutics Inc. Phosphonated oxazolidinones and uses thereof for the prevention and treatment of bone and joint infections
WO2009020616A1 (en) 2007-08-06 2009-02-12 Micurx Pharmaceuticals, Inc. Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
MX2011003820A (es) 2008-10-10 2011-06-16 Trius Therapeutics Metodos para preparar oxazolidinonas y composiciones que las contienen.
SG173497A1 (en) 2009-02-03 2011-09-29 Trius Therapeutics Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US8580767B2 (en) 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use

Also Published As

Publication number Publication date
HK1232221A1 (zh) 2018-01-05
EP2346858A2 (en) 2011-07-27
JP5773875B2 (ja) 2015-09-02
CA2738671C (en) 2018-05-01
RU2659792C1 (ru) 2018-07-04
US8604209B2 (en) 2013-12-10
AU2009303301B2 (en) 2014-09-11
EP2757104A1 (en) 2014-07-23
CN106220621A (zh) 2016-12-14
ES2744907T3 (es) 2020-02-26
JP2012505252A (ja) 2012-03-01
US20100093669A1 (en) 2010-04-15
RU2011115109A (ru) 2012-11-20
HK1200169A1 (en) 2015-07-31
KR20110071107A (ko) 2011-06-28
EP2757104B1 (en) 2019-08-14
KR101674146B1 (ko) 2016-11-08
CN106220621B (zh) 2019-06-11
CN102177156B (zh) 2016-08-24
SG195544A1 (en) 2013-12-30
SG10201702946RA (en) 2017-05-30
EP2346858B1 (en) 2019-08-07
US9328087B2 (en) 2016-05-03
AU2009303301A1 (en) 2010-04-15
CA2738671A1 (en) 2010-05-15
MX2011003820A (es) 2011-06-16
CN102177156A (zh) 2011-09-07
WO2010042887A2 (en) 2010-04-15
US20140206878A1 (en) 2014-07-24
ES2748505T3 (es) 2020-03-17
RU2556234C2 (ru) 2015-07-10
WO2010042887A3 (en) 2010-06-24

Similar Documents

Publication Publication Date Title
MX366793B (es) Metodos para preparar oxazolidinonas y composiciones que las contienen.
PH12013500827A1 (en) Chromobacterium bioactive compositions and metabolites
SG10201805840WA (en) Compositions and methods for stimulating hair growth
MX2010004028A (es) 4-[3-(4-ciclopropancarbonil-piperacin-1-carbonil)-4-fluoro-bencil ]-2h-ftalacin-1-ona.
UA105778C2 (uk) Піразол-4-n-алкоксикарбоксаміди як мікробіоциди, композиція, що їх містить, та спосіб боротьби із зараженням корисних рослин фітопагенними мікроорганізмами або його попередження з їх використанням
MX339939B (es) Generacion de plantas haploides y cruza de plantas mejorada.
WO2014201044A3 (en) Plant growth-promoting microorganisms and methods of use thereof
MX2013001045A (es) Organoide hepatico, sus usos y metodo de cultivo para obtenerlos.
PH12014501282A1 (en) Plant growth-promoting microbes and uses therefor
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
WO2011159770A3 (en) Methods and compositions for promoting hair growth
MY193277A (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
EP4296270A3 (en) A composition comprising stem cell cultures
MY152711A (en) Oral compositions containing a combination of natural extracts and related methods
MX338327B (es) Inhibidores de cdk.
MX2014014690A (es) Metodos y composiciones de fermentacion microbiana.
GB201000593D0 (en) Photo-bioreactor and method for cultivating biomass by photosynthesis
EP2563926A4 (en) MICROORGANISMS AND METHODS OF PROPYLENE BIOSYNTHESIS
WO2013005110A3 (en) Synthetic scaffolds and organ and tissue transplantation
PH12014501369A1 (en) Oral care compositions
IN2012DN03404A (es)
WO2009134368A3 (en) Methods of producing bacterial alginates
MX2014000507A (es) Composiciones y metodos para la produccion de isopreno.
MX2012007283A (es) Composiciones para vacunas.
PH12012502253A1 (en) Oral care compositions and methods